In our study, knockdown of RUNX1 significantly increased the proliferation inhibition of ovarian cancer cells treated with taxane, paclitaxel, and platinum drugs (carboplatin or cisplatin). The gene discussed is RUNX1; the disease is ovarian carcinoma.